Details of the Drug

General Information of Drug (ID: DMON3EQ)

Drug Name

NewGam

Indication

Disease Entry	ICD 11	Status	REF
Immune System disease	4A01-4B41	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01012323) Clinical Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Patients With Primary Immunodeficiency Diseases. U.S. National Institutes of Health.